# Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder

> **NCT07313371** · PHASE4 · RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Cocaine Use Disorder
- Crack Abuse or Dependence

## Interventions

- **DRUG:** clonidine
- **DRUG:** clonazepam 0,25 mg

## Key facts

- **NCT ID:** NCT07313371
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313371, "Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07313371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*